197 related articles for article (PubMed ID: 23880010)
1. Comparative assessment of absolute cardiovascular disease risk characterization from non-laboratory-based risk assessment in South African populations.
Gaziano TA; Pandya A; Steyn K; Levitt N; Mollentze W; Joubert G; Walsh CM; Motala AA; Kruger A; Schutte AE; Naidoo DP; Prakaschandra DR; Laubscher R
BMC Med; 2013 Jul; 11():170. PubMed ID: 23880010
[TBL] [Abstract][Full Text] [Related]
2. Comparison of Nonblood-Based and Blood-Based Total CV Risk Scores in Global Populations.
Gaziano TA; Abrahams-Gessel S; Alam S; Alam D; Ali M; Bloomfield G; Carrillo-Larco RM; Dorairaj P; Gutierrez L; Irazola V; Levitt NS; Miranda JJ; Bernabe-Ortiz A; Pandya A; Rubinstein A; Steyn K; Xavier D; Yan LL
Glob Heart; 2016 Mar; 11(1):37-46.e2. PubMed ID: 27102021
[TBL] [Abstract][Full Text] [Related]
3. A comparative assessment of non-laboratory-based versus commonly used laboratory-based cardiovascular disease risk scores in the NHANES III population.
Pandya A; Weinstein MC; Gaziano TA
PLoS One; 2011; 6(5):e20416. PubMed ID: 21655241
[TBL] [Abstract][Full Text] [Related]
4. Cardiovascular disease risk prediction in sub-Saharan African populations - Comparative analysis of risk algorithms in the RODAM study.
Boateng D; Agyemang C; Beune E; Meeks K; Smeeth L; Schulze MB; Addo J; de-Graft Aikins A; Galbete C; Bahendeka S; Danquah I; Agyei-Baffour P; Owusu-Dabo E; Mockenhaupt FP; Spranger J; Kengne AP; Grobbee DE; Klipstein-Grobusch K
Int J Cardiol; 2018 Mar; 254():310-315. PubMed ID: 29407113
[TBL] [Abstract][Full Text] [Related]
5. Laboratory-based and office-based risk scores and charts to predict 10-year risk of cardiovascular disease in 182 countries: a pooled analysis of prospective cohorts and health surveys.
Ueda P; Woodward M; Lu Y; Hajifathalian K; Al-Wotayan R; Aguilar-Salinas CA; Ahmadvand A; Azizi F; Bentham J; Cifkova R; Di Cesare M; Eriksen L; Farzadfar F; Ferguson TS; Ikeda N; Khalili D; Khang YH; Lanska V; León-Muñoz L; Magliano DJ; Margozzini P; Msyamboza KP; Mutungi G; Oh K; Oum S; Rodríguez-Artalejo F; Rojas-Martinez R; Valdivia G; Wilks R; Shaw JE; Stevens GA; Tolstrup JS; Zhou B; Salomon JA; Ezzati M; Danaei G
Lancet Diabetes Endocrinol; 2017 Mar; 5(3):196-213. PubMed ID: 28126460
[TBL] [Abstract][Full Text] [Related]
6. Predicted and observed cardiovascular disease in South Asians: application of FINRISK, Framingham and SCORE models to Newcastle Heart Project data.
Bhopal R; Fischbacher C; Vartiainen E; Unwin N; White M; Alberti G
J Public Health (Oxf); 2005 Mar; 27(1):93-100. PubMed ID: 15749725
[TBL] [Abstract][Full Text] [Related]
7. Application of Framingham risk estimates to ethnic minorities in United Kingdom and implications for primary prevention of heart disease in general practice: cross sectional population based study.
Cappuccio FP; Oakeshott P; Strazzullo P; Kerry SM
BMJ; 2002 Nov; 325(7375):1271. PubMed ID: 12458243
[TBL] [Abstract][Full Text] [Related]
8. Comparing six cardiovascular risk prediction models in Haiti: implications for identifying high-risk individuals for primary prevention.
Yan LD; Lookens Pierre J; Rouzier V; Théard M; Apollon A; St Preux S; Kingery JR; Jamerson KA; Deschamps M; Pape JW; Safford MM; McNairy ML
BMC Public Health; 2022 Mar; 22(1):549. PubMed ID: 35305599
[TBL] [Abstract][Full Text] [Related]
9. Ethnicity and prediction of cardiovascular disease: performance of QRISK2 and Framingham scores in a U.K. tri-ethnic prospective cohort study (SABRE--Southall And Brent REvisited).
Tillin T; Hughes AD; Whincup P; Mayet J; Sattar N; McKeigue PM; Chaturvedi N;
Heart; 2014 Jan; 100(1):60-7. PubMed ID: 24186564
[TBL] [Abstract][Full Text] [Related]
10. A comparison of laboratory-based and office-based Framingham risk scores to predict 10-year risk of cardiovascular diseases: a population-based study.
Dehghan A; Ahmadnia Motlagh S; Khezri R; Rezaei F; Aune D
J Transl Med; 2023 Oct; 21(1):687. PubMed ID: 37789412
[TBL] [Abstract][Full Text] [Related]
11. Agreement Between Cardiovascular Disease Risk Scores in Resource-Limited Settings: Evidence from 5 Peruvian Sites.
Bazo-Alvarez JC; Quispe R; Peralta F; Poterico JA; Valle GA; Burroughs M; Pillay T; Gilman RH; Checkley W; Malaga G; Smeeth L; Bernabé-Ortiz A; Miranda JJ;
Crit Pathw Cardiol; 2015 Jun; 14(2):74-80. PubMed ID: 26102017
[TBL] [Abstract][Full Text] [Related]
12. Comparative performance of pooled cohort equations and Framingham risk scores in cardiovascular disease risk classification in a slum setting in Nairobi Kenya.
Wekesah FM; Mutua MK; Boateng D; Grobbee DE; Asiki G; Kyobutungi CK; Klipstein-Grobusch K
Int J Cardiol Heart Vasc; 2020 Jun; 28():100521. PubMed ID: 32373711
[TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness of the non-laboratory based Framingham algorithm in primary prevention of cardiovascular disease: A simulated analysis of a cohort of African American adults.
Kariuki JK; Gona P; Leveille SG; Stuart-Shor EM; Hayman LL; Cromwell J
Prev Med; 2018 Jun; 111():415-422. PubMed ID: 29224996
[TBL] [Abstract][Full Text] [Related]
14. Comparison of different cardiovascular risk tools used in HIV patient cohorts in sub-Saharan Africa; do we need to include laboratory tests?
Mubiru F; Castelnuovo B; Reynolds SJ; Kiragga A; Tibakabikoba H; Owarwo NC; Kambugu A; Lamorde M; Parkes-Ratanshi R
PLoS One; 2021; 16(1):e0243552. PubMed ID: 33507945
[TBL] [Abstract][Full Text] [Related]
15. Ten-year risk of fatal cardiovascular disease and its association with metabolic risk factors among waste pickers in South Africa.
Made F; Nonterah EA; Tlotleng N; Ntlebi V; Naicker N
BMC Cardiovasc Disord; 2021 Jul; 21(1):336. PubMed ID: 34246223
[TBL] [Abstract][Full Text] [Related]
16. Multimodality Strategy for Cardiovascular Risk Assessment: Performance in 2 Population-Based Cohorts.
de Lemos JA; Ayers CR; Levine BD; deFilippi CR; Wang TJ; Hundley WG; Berry JD; Seliger SL; McGuire DK; Ouyang P; Drazner MH; Budoff M; Greenland P; Ballantyne CM; Khera A
Circulation; 2017 May; 135(22):2119-2132. PubMed ID: 28360032
[TBL] [Abstract][Full Text] [Related]
17. Rheumatoid arthritis-specific cardiovascular risk scores are not superior to general risk scores: a validation analysis of patients from seven countries.
Crowson CS; Gabriel SE; Semb AG; van Riel PLCM; Karpouzas G; Dessein PH; Hitchon C; Pascual-Ramos V; Kitas GD;
Rheumatology (Oxford); 2017 Jul; 56(7):1102-1110. PubMed ID: 28339992
[TBL] [Abstract][Full Text] [Related]
18. Cardiovascular disease risk profile and management practices in 45 low-income and middle-income countries: A cross-sectional study of nationally representative individual-level survey data.
Peiris D; Ghosh A; Manne-Goehler J; Jaacks LM; Theilmann M; Marcus ME; Zhumadilov Z; Tsabedze L; Supiyev A; Silver BK; Sibai AM; Norov B; Mayige MT; Martins JS; Lunet N; Labadarios D; Jorgensen JMA; Houehanou C; Guwatudde D; Gurung MS; Damasceno A; Aryal KK; Andall-Brereton G; Agoudavi K; McKenzie B; Webster J; Atun R; Bärnighausen T; Vollmer S; Davies JI; Geldsetzer P
PLoS Med; 2021 Mar; 18(3):e1003485. PubMed ID: 33661979
[TBL] [Abstract][Full Text] [Related]
19. Performance of Framingham cardiovascular risk scores by ethnic groups in New Zealand: PREDICT CVD-10.
Riddell T; Wells S; Jackson R; Lee AW; Crengle S; Bramley D; Ameratunga S; Pylypchuk R; Broad J; Marshall R; Kerr A
N Z Med J; 2010 Feb; 123(1309):50-61. PubMed ID: 20186242
[TBL] [Abstract][Full Text] [Related]
20. Comparability of total cardiovascular disease risk estimates using laboratory and non-laboratory based assessments in urban-dwelling South Africans: the CRIBSA study.
Peer N; Lombard C; Steyn K; Gaziano T; Levitt N
S Afr Med J; 2014 Aug; 104(10):691-6. PubMed ID: 25363056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
